Literature DB >> 23928954

Where to for pelvic organ prolapse treatment after the FDA pronouncements? Reply to Pelikan.

J M van Geelen1, P L Dwyer.   

Abstract

Mesh：

Year:  2013        PMID： 23928954     DOI： 10.1007/s00192-013-2188-6

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN： 0937-3462            Impact factor:   2.894


× No keyword cloud information.
  5 in total

Review 1.  Surgical management of pelvic organ prolapse in women.

Authors:  C Maher; K Baessler; C M A Glazener; E J Adams; S Hagen
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

2.  Where to for pelvic organ prolapse treatment after the FDA pronouncements? Comment.

Authors:  H M P Pelikan
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

3.  Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse.

Authors:  Ingrid Nygaard; Linda Brubaker; Halina M Zyczynski; Geoffrey Cundiff; Holly Richter; Marie Gantz; Paul Fine; Shawn Menefee; Beri Ridgeway; Anthony Visco; Lauren Klein Warren; Min Zhang; Susan Meikle
Journal:  JAMA       Date:  2013-05-15       Impact factor: 56.272

4.  Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal vault prolapse: a prospective randomized study.

Authors:  Christopher F Maher; Aymen M Qatawneh; Peter L Dwyer; Marcus P Carey; Ann Cornish; Philip J Schluter
Journal:  Am J Obstet Gynecol       Date:  2004-01       Impact factor: 8.661

Review 5.  Where to for pelvic organ prolapse treatment after the FDA pronouncements? A systematic review of the recent literature.

Authors:  J M van Geelen; P L Dwyer
Journal:  Int Urogynecol J       Date:  2013-01-10       Impact factor: 2.894
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.